Private
Cancer
Screening
London

Book Your Blood Test for Cancer Today
Appointments Available Across London

Private Cancer Screening London

Why HrC Genomics?

test4cancer - samples processed using Illumina Novoseq 6000 Sequencers
Illumina NovoSeq 6000 Sequencer

Screening for Cancer with HrC

  • Early Cancer Detection Technology i.e., can detect cancer presence at Stage 1 or before.
  • Only test to give a reading when cancer is NOT present.
  • Indicates risk of cancer being present for multiple cancer types.
  • Designed to be used as an annual screening test to monitor ongoing risk of cancer.
  • Samples processed using Next Generation Sequencing (NGS) technology.
  • Targets genetic biomarkers known to be key hallmarks of cancer initiation.
  • Requires a 12ml sample of blood taken by a Professional Phlebotomist at one of our approved locations in London.

Onco B3 (Blood Based Biopsy)

Onco Bprovides a Full Cancer Health Check of all the organs impacted by cancer. This is possible due to the discovery by our scientists of pluripotent progenitor stem cells circulating in peripheral blood. This type of stem cell contains the signature of the organ from where it originated meaning that once the transcriptome analysis of the cell has been performed, detailed information relating to the tumour(s) can be provided i.e., Type/Sub-Type of Cancer, Primary/Secondary Organ, Next Organ to be Impacted (if any), Genetic Mutations, Altered Expressions & Dysregulated Pathways.

Onco B is a simple blood test that provides all the information required to guide treatment, for all organs impacted by cancer, without the need of a tissue biopsy.

Being a simple blood test, Onco Bcan be performed as often as required to help monitor responsiveness to treatment as well as being able to conclusively confirm remission for cancer survivors.

Simple Blood Test, Amazing Results

  • Full Cancer Health Check of all major organs impacted by cancer.
  • Detailed report issued containing all the essential information required by an Oncologist to determine best treatment options.
  • Identifies dysregulated pathways, altered expressions & genetic mutations.
  • Identifies type & sub-type of cancer present.
  • Identifies primary and secondary organs impacted.
  • Works on solid tumours, blood cancers and soft tissue sarcomas.
  • Can be used to monitor responsiveness to cancer treatment.
  • Can be used to conclusively confirm remission in cancer survivors.
  • Can be used to provide a 2nd opinion on a cancer diagnosis.
  • Simple blood test that can be taken as often as necessary unlike tissue biopsies or PET scans.
  • Pre-consultation and Post-consultation meeting with a healthcare professional included.
Test for Cancer - Blood Based Biopsy

Why Monitor for Early Indicators of Cancer?

Cancer’s unpredictable nature makes it a formidable foe. Early detection is critical for successful treatment and survival, but often, cancer develops silently.

HrC Genomics offers a proactive solution. This technology analyses specific biomarkers in your blood, providing insights into your cancer risk before symptoms appear.

This is especially crucial for individuals at high risk due to family history, exposure to carcinogens (like asbestos or radon), or lifestyle factors like smoking. Understanding your risk empowers you to take action.

Early detection through blood testing allows for timely intervention, significantly improving outcomes and potentially saving lives. It’s a proactive step towards safeguarding your health.